Cargando…
Identification of methylation sites and signature genes with prognostic value for luminal breast cancer
BACKGROUND: Robust and precise molecular prognostic predictors for luminal breast cancer are required. This study aimed to identify key methylation sites in luminal breast cancer, as well as precise molecular tools for predicting prognosis. METHODS: We compared methylation levels of normal and lumin...
Autores principales: | Xiao, Bin, Chen, Lidan, Ke, Yongli, Hang, Jianfeng, Cao, Ling, Zhang, Rong, Zhang, Weiyun, Liao, Yang, Gao, Yang, Chen, Jianyun, Li, Li, Hao, Wenbo, Sun, Zhaohui, Li, Linhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896050/ https://www.ncbi.nlm.nih.gov/pubmed/29642861 http://dx.doi.org/10.1186/s12885-018-4314-9 |
Ejemplares similares
-
Correlational study on mitochondrial DNA mutations as potential risk factors in breast cancer
por: Li, Linhai, et al.
Publicado: (2016) -
Glutamate Ionotropic Receptor Kainate Type Subunit 3 (GRIK3) promotes epithelial‐mesenchymal transition in breast cancer cells by regulating SPDEF/CDH1 signaling
por: Xiao, Bin, et al.
Publicado: (2019) -
Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p
por: Xiao, Bin, et al.
Publicado: (2019) -
Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma
por: Dong, Min, et al.
Publicado: (2020) -
A TIMM17A Regulatory Network Contributing to Breast Cancer
por: Cai, Jiajia, et al.
Publicado: (2021)